Furthermore,in vitroandin vivo analyses demonstrate that TMEM106A knockdown promotes HCC progression by inducting EMT through the Erk1/2/Slug signaling pathway which may serve as a potential therapeutic target. This evidence concerns the gene TMEM106A and hepatocellular carcinoma.